Articles by Patrick Daly
Maintenance with cetuximab monotherapy appeared to improve PFS and OS in patients with metastatic colorectal cancer.
A study found key tumor heterogeneities, including Ki-67 indices, might contribute to disease progression in GEP-NETs.
Lu-177-dotatate in PRRT appeared to treat GEP-NETs, though prior internal radiation may impede responses or worsen survival.
Fruquintinib meaningfully improved overall survival in patients with refractory metastatic colorectal cancer versus placebo.
Systemic chemotherapy did not show any benefit in patients with inoperable low-grade mucinous appendiceal adenocarcinoma.
Eradication therapy for chronic Helicobacter pylori (H. pylori) infection reduces the risk for gastric cancer (GC), ...
In a recent study, researchers investigated the value of serum exosomal and serum glypican 1 (GPC-1) in predicting ...
In a phase 1b trial, researchers evaluated the safety and efficacy profiles of combined S-1, irinotecan, and oxaliplatin ...
In a randomized controlled trial, published in the Journal of Cancer Research and Therapeutics, researchers compared ...
According to an article in BMC Cancer, the most accurate inflammation and nutritional biomarkers for predicting the ...
According to Dirk Weyhe and collaborating researchers, patients experience significantly reduced physical and ...
Researchers performed a randomized clinical trial to examine the efficacy of bevacizumab and gemcitabine plus cisplatin ...
Researchers investigated the role of a protein in the molecules interacting with CasL (MICAL) family, MICAL-like protein ...
According to a study, published in Frontiers in Oncology, pancreatic ductal adenocarcinoma (PDAC) is one of the most ...
Over half of colorectal cancers (CRCs) are wired to RAS/RAF/MEK/ERK pathway oncogenic signaling; However, the activity ...
According to an article, published in the International Journal of Radiation Oncology, Biology, Physics, there is a ...
630 Madison Ave.
Manalapan, NJ 07726
About Column
Contribute Column
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.